Search Press releases

17 May 2024

Transparency notification Wellington

Read More
17 May 2024

Acquisition of own shares

Read More
14 May 2024

New data published in the Journal of Neurology show clinically meaningful improvement of fatigue in generalized myasthenia gravis (gMG) with ZILBRYSQ[®]▼ (zilucoplan)

Read More
10 May 2024

Acquisition of own shares

Read More
8 May 2024

UCB presents final open-label extension FINTEPLA®▼(fenfluramine)[1] data at International Child Neurology Congress (ICNC) Annual Meeting

Read More
3 May 2024

Acquisition of own shares

Read More

Stay up-to-date on the latest news and information from UCB